Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Clinical trial NCT02748304 · TERMINATED
Trial details
- NCT number
- NCT02748304
- Sponsor
- Fudan University
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-02-11
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.